Beam Therapeutics (BEAM) Shares Outstanding (Entity) (2019 - 2026)
Powered by 
Analysis
Beam Therapeutics (BEAM) Shares Outstanding (Entity) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.58 Bn | 130.73 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 85.33 Bn | 77.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 63.43 Bn | 58.24 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.84 Bn | 52.70 Bn | 52.00 Mn | 399.00 Mn |
| 5 | Revolution Medicines | 44.01 Bn | 44.01 Bn | - | 214.24 Mn |
| 6 | BeOne Medicines | 39.93 Bn | 34.83 Bn | 1.53 Bn | 113.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.47 Bn | 32.16 Bn | 992.69 Mn | 133.73 Mn |
| 8 | Royalty Pharma | 28.39 Bn | 27.56 Bn | - | 575.00 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 218.28 Mn |
| 10 | Beam Therapeutics | 3.09 Bn | 3.09 Bn | - | 103.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 103.26 Mn |
| Mar 31, 2026 | 102.74 Mn |
| Dec 31, 2025 | 101.75 Mn |
| Sep 30, 2025 | 101.36 Mn |
| Jun 30, 2025 | 100.76 Mn |
| Mar 31, 2025 | 100.56 Mn |
| Dec 31, 2024 | 83.63 Mn |
| Sep 30, 2024 | 82.56 Mn |
| Jun 30, 2024 | 82.39 Mn |
| Mar 31, 2024 | 82.28 Mn |
| Dec 31, 2023 | 81.63 Mn |
| Sep 30, 2023 | 79.38 Mn |
| Jun 30, 2023 | 77.95 Mn |
| Mar 31, 2023 | 74.44 Mn |
| Dec 31, 2022 | 71.28 Mn |
| Sep 30, 2022 | 70.46 Mn |
| Jun 30, 2022 | 70.31 Mn |
| Mar 31, 2022 | 69.75 Mn |
| Dec 31, 2021 | 68.39 Mn |
| Sep 30, 2021 | 67.73 Mn |